Author + information
- Spencer B. King III, MD, MACC, Editor-in-Chief, JACC: Cardiovascular Interventions⁎ ()
- ↵⁎Address correspondence to:
Spencer B. King III, MD, MACC, Editor-in-Chief, JACC: Cardiovascular Interventions, Saint Joseph's Heart and Vascular Institute, 5665 Peachtree Dunwoody Road, NE, Atlanta, Georgia 30342.
In this election year, the Internet is rife with rumors. Like the politicians, the interventional community is not immune to misinformation. Recent headlines have stated that the American College of Cardiology (ACC) is “appeasing” interventionalists and “handing over the reins” of the Innovation in Intervention (i2) Summit. I have been asked about this by quite a few of our colleagues. In an attempt to understand the answers to that question, I have contacted various people for their input. Here are the facts as I understand them.
The ACC and the Society for Cardiovascular Angiography and Interventions (SCAI) entered into an equal partnership to offer one spring interventional meeting that occurs in conjunction with the ACC's Annual Scientific Session. Despite some challenges, like a separate registration fee, the 2008 meeting was highly successful with over 4,400 attendees and a superb scientific program. There was, however, a perceived loss of intimacy of the SCAI annual meeting, and the time for committee meetings and other business activities was somewhat compromised. The leadership of SCAI decided that its annual meeting should return to a separate venue and time.
This vacuum left the question of how to best conduct the i2 Summit. The primary goal of its creation, according to Dr. W. Douglas Weaver, President of the ACC, was to provide the highest quality scientific session to those ACC members engaged in interventional cardiovascular endeavors. He said, “This venue is unique for interventionalists because they have the opportunity to integrate their interventional experiences with the rest of cardiology.” For most interventional cardiologists, the rest of cardiology is indeed the major part of their practice.
Since the inception of the i2 Summit, the ACC has outsourced some of the organizational aspects to other professional meeting planners. Skills such as orchestrating live case transmissions and other specialized activities were contracted out to others.
Why the Cardiovascular Research Foundation (CRF)? In response to the question posed by some, Dr. Weaver explained that the CRF has significant expertise in interventional meetings, and the ACC wanted to build on the success of the i2 Summit over the years by bringing in a strategic partner. Dr. Gregg Stone of CRF said, “The i2 Summit remains a wholly owned ACC meeting, and CRF is proud to be associated with it.”
The relationship between the ACC and the CRF, therefore, is contractual to provide much-needed meeting services, but, in addition, members of CRF will participate in the program committee. Drs. David Holmes and George Dangas will co-chair the first meetings, and an advisory board of representation of the ACC board, the ACC interventional section, and the CRF will oversee the activities of the meeting. This advisory group will report ultimately to the Board of Trustees of the ACC.
Dr. Bonnie Weiner, President of the SCAI, explained that the decision to hold a separate meeting was in no way a split with the ACC, but rather a desire to hold a more focused meeting concentrating on interventional issues exclusively and, at the same time, provide a venue for the business activities of the SCAI.
Education for Interventional Cardiologists
It seems clear that all parties are committed to furthering the education of interventional cardiologists. The ACC/SCAI relationship is deep in that many fellows of the College hold fellowship in the SCAI, and almost all SCAI members are also members of the ACC. The SCAI headquarters are housed in ACC's Heart House in Washington, DC, and many of the College's extensive advocacy initiatives are supported by the SCAI. Numerous educational activities are co-sponsored, and the College has welcomed the SCAI to participate in the ACC/AHA guideline process and other document development on subjects relevant to interventional cardiology.
Dr. Weaver said, “Far from appeasing the interventionalists, the College continues to strive for comprehensive educational offerings for physicians engaged in interventional cardiology to meet their needs, as well as the needs of all cardiologists.”
Education in cardiology, and especially interventional cardiology, is evolving and should do so in order to meet the needs of the practitioners and scientists in the field. The current i2 Summit structure that the College envisions takes advantage of some unique capabilities of the CRF organization. The participation of many of you will be necessary to take this very successful endeavor and make it even better.
- American College of Cardiology Foundation